Literature DB >> 26363444

Low Counts of B Cells, Natural Killer Cells, Monocytes, Dendritic Cells, Basophils, and Eosinophils are Associated with Postengraftment Infections after Allogeneic Hematopoietic Cell Transplantation.

Peter J Podgorny1, Laura M Pratt2, Yiping Liu2, Poonam Dharmani-Khan2, Joanne Luider3, Iwona Auer-Grzesiak3, Adnan Mansoor3, Tyler S Williamson2, Alejandra Ugarte-Torres2, Mette Hoegh-Petersen2, Faisal M Khan3, Loree Larratt4, Victor H Jimenez-Zepeda2, Douglas A Stewart2, James A Russell2, Andrew Daly2, Jan Storek2.   

Abstract

Hematopoietic cell transplant (HCT) recipients are immunocompromised and thus predisposed to infections. We set out to determine the deficiency of which immune cell subset(s) may predispose to postengraftment infections. We determined day 28, 56, 84, and 180 blood counts of multiple immune cell subsets in 219 allogeneic transplant recipients conditioned with busulfan, fludarabine, and Thymoglobulin. Deficiency of a subset was considered to be associated with infections if the low subset count was significantly associated with subsequent high infection rate per multivariate analysis in both discovery and validation cohorts. Low counts of monocytes (total and inflammatory) and basophils, and low IgA levels were associated with viral infections. Low plasmacytoid dendritic cell (PDC) counts were associated with bacterial infections. Low inflammatory monocyte counts were associated with fungal infections. Low counts of total and naive B cells, total and CD56(high) natural killer (NK) cells, total and inflammatory monocytes, myeloid dendritic cells (MDCs), PDCs, basophils and eosinophils, and low levels of IgA were associated with any infections (due to any pathogen or presumed). In conclusion, deficiencies of B cells, NK cells, monocytes, MDCs, PDCs, basophils, eosinophils, and/or IgA plasma cells appear to predispose to postengraftment infections.
Copyright © 2016 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hematopoietic; Immune cells; Infections; Monocytes; Transplantation

Mesh:

Substances:

Year:  2015        PMID: 26363444     DOI: 10.1016/j.bbmt.2015.09.003

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  12 in total

Review 1.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report.

Authors:  Juan Gea-Banacloche; Krishna V Komanduri; Paul Carpenter; Sophie Paczesny; Stefanie Sarantopoulos; Jo-Anne Young; Nahed El Kassar; Robert Q Le; Kirk R Schultz; Linda M Griffith; Bipin N Savani; John R Wingard
Journal:  Biol Blood Marrow Transplant       Date:  2016-10-14       Impact factor: 5.742

2.  Tau associated peripheral and central neurodegeneration: Identification of an early imaging marker for tauopathy.

Authors:  Alexandra Marquez; Lucie S Guernsey; Katie E Frizzi; Morgan Cundiff; Isabel Constantino; Nabeel Muttalib; Fernanda Arenas; Xiajun Zhou; Sze Hway Lim; Maryam Ferdousi; Georgios Ponirakis; Monty Silverdale; Christopher Kobylecki; Matthew Jones; Andrew Marshall; Rayaz A Malik; Corinne G Jolivalt
Journal:  Neurobiol Dis       Date:  2021-01-19       Impact factor: 5.996

3.  Relation between Acute GVHD and NK Cell Subset Reconstitution Following Allogeneic Stem Cell Transplantation.

Authors:  Evelyn Ullrich; Emilia Salzmann-Manrique; Shahrzad Bakhtiar; Melanie Bremm; Stephanie Gerstner; Eva Herrmann; Peter Bader; Petra Hoffmann; Ernst Holler; Matthias Edinger; Daniel Wolff
Journal:  Front Immunol       Date:  2016-12-22       Impact factor: 7.561

4.  Stem cell transplantation during cancer.

Authors:  Xiao-Ying Zhang; Pei-Ying Zhang
Journal:  Oncol Lett       Date:  2016-10-13       Impact factor: 2.967

5.  Mononuclear-macrophages but not neutrophils act as major infiltrating anti-leptospiral phagocytes during leptospirosis.

Authors:  Xu Chen; Shi-Jun Li; David M Ojcius; Ai-Hua Sun; Wei-Lin Hu; Xu'ai Lin; Jie Yan
Journal:  PLoS One       Date:  2017-07-11       Impact factor: 3.240

6.  Contemporary analysis of functional immune recovery to opportunistic and vaccine-preventable infections after allogeneic haemopoietic stem cell transplantation.

Authors:  Harini D de Silva; Rosemary A Ffrench; Maya Korem; Eva Orlowski; David J Curtis; Andrew Spencer; Sharon Avery; Sushrut Patil; Catherine Orla Morrissey
Journal:  Clin Transl Immunology       Date:  2018-10-05

7.  Shaping of CD56bri Natural Killer Cells in Patients With Steroid-Refractory/Resistant Acute Graft-vs.-Host Disease via Extracorporeal Photopheresis.

Authors:  Ming Ni; Lei Wang; Mingya Yang; Brigitte Neuber; Leopold Sellner; Angela Hückelhoven-Krauss; Maria-Luisa Schubert; Thomas Luft; Ute Hegenbart; Stefan Schönland; Patrick Wuchter; Bao-An Chen; Volker Eckstein; William Krüger; Ronit Yerushalmi; Katia Beider; Arnon Nagler; Carsten Müller-Tidow; Peter Dreger; Michael Schmitt; Anita Schmitt
Journal:  Front Immunol       Date:  2019-03-20       Impact factor: 7.561

8.  Immune infiltration in nasopharyngeal carcinoma based on gene expression.

Authors:  Meng-Si Luo; Guan-Jiang Huang; Bao-Xinzi Liu
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

9.  Quantification of Early-Stage Myeloid-Derived Suppressor Cells in Cancer Requires Excluding Basophils.

Authors:  Anm Nazmul H Khan; Tiffany R Emmons; Jerry T Wong; Emad Alqassim; Kelly L Singel; Jaron Mark; Brandon E Smith; Joseph D Tario; Kevin H Eng; Kirsten B Moysich; Kunle Odunsi; Scott I Abrams; Brahm H Segal
Journal:  Cancer Immunol Res       Date:  2020-04-01       Impact factor: 12.020

10.  Measuring the cellular memory B cell response after vaccination in patients after allogeneic stem cell transplantation.

Authors:  Julia Winkler; Hannes Tittlbach; Andrea Schneider; Corinna Buchstaller; Andreas Mayr; Ingrid Vasova; Wolf Roesler; Michael Mach; Andreas Mackensen; Thomas H Winkler
Journal:  Ann Hematol       Date:  2020-06-09       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.